Estrella Immunopharma Stock Market Value
| ESLA Stock | 1.23 0.15 10.87% |
| Symbol | Estrella |
Estrella Immunopharma Company Valuation
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Estrella Immunopharma. If investors know Estrella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Estrella Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.24) | Return On Assets (1.22) | Return On Equity (2.78) |
The market value of Estrella Immunopharma is measured differently than its book value, which is the value of Estrella that is recorded on the company's balance sheet. Investors also form their own opinion of Estrella Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Estrella Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Estrella Immunopharma's market value can be influenced by many factors that don't directly affect Estrella Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Estrella Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Estrella Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Estrella Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Estrella Immunopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Estrella Immunopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Estrella Immunopharma.
| 12/19/2023 |
| 12/13/2024 |
If you would invest 0.00 in Estrella Immunopharma on December 19, 2023 and sell it all today you would earn a total of 0.00 from holding Estrella Immunopharma or generate 0.0% return on investment in Estrella Immunopharma over 360 days. Estrella Immunopharma is related to or competes with Puma Biotechnology, Iovance Biotherapeutics, Day One, Inozyme Pharma, Zentalis Pharmaceuticals, Syndax Pharmaceuticals, and Protagonist Therapeutics. Estrella Immunopharma is entity of United States More
Estrella Immunopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Estrella Immunopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Estrella Immunopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.88 | |||
| Information Ratio | 0.0751 | |||
| Maximum Drawdown | 41.75 | |||
| Value At Risk | (10.48) | |||
| Potential Upside | 10.34 |
Estrella Immunopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Estrella Immunopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Estrella Immunopharma's standard deviation. In reality, there are many statistical measures that can use Estrella Immunopharma historical prices to predict the future Estrella Immunopharma's volatility.| Risk Adjusted Performance | 0.0744 | |||
| Jensen Alpha | 0.7329 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0822 | |||
| Treynor Ratio | (1.04) |
Estrella Immunopharma Backtested Returns
Estrella Immunopharma appears to be abnormally volatile, given 3 months investment horizon. Estrella Immunopharma secures Sharpe Ratio (or Efficiency) of 0.0883, which denotes the company had a 0.0883% return per unit of risk over the last 3 months. By reviewing Estrella Immunopharma's technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please utilize Estrella Immunopharma's Downside Deviation of 6.88, coefficient of variation of 1111.59, and Mean Deviation of 5.58 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Estrella Immunopharma holds a performance score of 6. The firm shows a Beta (market volatility) of -0.64, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Estrella Immunopharma are expected to decrease at a much lower rate. During the bear market, Estrella Immunopharma is likely to outperform the market. Please check Estrella Immunopharma's treynor ratio, expected short fall, day typical price, as well as the relationship between the potential upside and daily balance of power , to make a quick decision on whether Estrella Immunopharma's price patterns will revert.
Auto-correlation | 0.19 |
Very weak predictability
Estrella Immunopharma has very weak predictability. Overlapping area represents the amount of predictability between Estrella Immunopharma time series from 19th of December 2023 to 16th of June 2024 and 16th of June 2024 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Estrella Immunopharma price movement. The serial correlation of 0.19 indicates that over 19.0% of current Estrella Immunopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Estrella Immunopharma lagged returns against current returns
Autocorrelation, which is Estrella Immunopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Estrella Immunopharma's stock expected returns. We can calculate the autocorrelation of Estrella Immunopharma returns to help us make a trade decision. For example, suppose you find that Estrella Immunopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Estrella Immunopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Estrella Immunopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Estrella Immunopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Estrella Immunopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Estrella Immunopharma Lagged Returns
When evaluating Estrella Immunopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Estrella Immunopharma stock have on its future price. Estrella Immunopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Estrella Immunopharma autocorrelation shows the relationship between Estrella Immunopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Estrella Immunopharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Estrella Immunopharma is a strong investment it is important to analyze Estrella Immunopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Estrella Immunopharma's future performance. For an informed investment choice regarding Estrella Stock, refer to the following important reports:Check out Estrella Immunopharma Correlation, Estrella Immunopharma Volatility and Estrella Immunopharma Alpha and Beta module to complement your research on Estrella Immunopharma. For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Estrella Immunopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.